Clinical Value of EZH2 in Hepatocellular Carcinoma and Its Potential for Target Therapy

Background and objectives: EZH2 is overexpressed in hepatocellular carcinoma (HCC) and is correlated with poor prognosis. However, its clinical significance and molecular mechanism have not been studied in HCC. In this study, clinical and prognostic values of EZH2 was studied using Total Cancer Geno...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, An-Na, Jung, Soo-Jung, Lee, Jae-Ho, Lee, Hyunsu, Park, Seung Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877936/
https://www.ncbi.nlm.nih.gov/pubmed/35208478
http://dx.doi.org/10.3390/medicina58020155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877936/
https://www.ncbi.nlm.nih.gov/pubmed/35208478
http://dx.doi.org/10.3390/medicina58020155

Ejemplares similares